Adults 21 to 80, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in Boston Carpal Tunnel Syndrome (BCTQ) ScorePrimary· Baseline, 60 days
The Boston Carpal Tunnel Syndrome questionnaire (BCTQ) assesses symptom severity and overall function of subjects with Carpel Tunnel Syndrome. The questionnaire consists of two sections: 1. Symptom Severity (11 questions) and 2. Functional Status (8 questions). Subjects are asked to rate each question on a scale of 1 to 5. The mean score for each section is calculated by summing the individual question responses and diving by the number of questions resulting in a total score ranging from 1 to 5, with higher scores indicating greater symptom severity and dysfunction.
Group
Value
95% CI
Carpal Tunnel Syndrome
-0.5
± 0.6
Adverse events — posted to ClinicalTrials.gov
Time frame: Adverse events were collected from the time of investigational product administration through post-treatment follow up, approximately 180 days..
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
This research study is being conducted to investigate the safety and effectiveness of the drug Fisetin for mild or moderate carpal tunnel syndrome (CTS).
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity
· Phase 1, PHASE2
· recruiting
NCT07195318 — Fisetin Supplementation for Healthy Aging
· NA
· recruiting
NCT07025226 — Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of P
· EARLY_PHASE1
· recruiting
NCT06113016 — Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
· Phase 2
· recruiting
NCT06133634 — Fisetin to Improve Vascular Function in Older Adults
· Phase 1, PHASE2
· active not recruiting
Other recruiting trials for Carpal Tunnel Syndrome
Currently open trials in the same condition.
NCT07312123 — A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome
· NA
· recruiting
NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method
· NA
· recruiting
NCT07414069 — High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes
· NA
· recruiting
NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome
· recruiting
NCT06905769 — Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient
· NA
· active not recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peter C. Amadio, M.D.
Last refreshed: 24 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05416515.